Insulin Detemir Co-Administered With Liraglutide: An Open Label Trial to Assess Insulin Detemir and Liraglutide Pharmacokinetics and Pharmacodynamics Following Liraglutide Therapy in Subjects With Type 2 Diabetes.
Phase of Trial: Phase I
Latest Information Update: 31 Jan 2017
At a glance
- Drugs Insulin detemir; Liraglutide
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 19 Sep 2009 Actual patient number (32) added as reported by ClinicalTrials.gov.
- 19 Sep 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 19 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.